Drug Database
Back to search

Belgium· BE-AMP-SAM382453-00

Irbesartan/Hydrochlorothiazide Liconsa 300 mg - 12,5 mg

A irbesartan und diuretika product containing irbesartan, registered in Belgium by Laboratorios Liconsa. The same ATC class is registered in 13 of our 19 countries.

ATC C09DA04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedIrbesartan/Hydrochlorothiazide Licons…ATCC09DA04REGISTER NO.BE-AMP-SAM382453-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about irbesartanAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Irbesartan und diuretika is registered in 13 of 19 countries.

Countries holding a registration under ATC C09DA04 (irbesartan und diuretika), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 9 of them publish a price we can compare per daily dose
Search irbesartan und diuretika products by name

Irbesartan und diuretika · ATC C09DA04

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Irbesartan
Manufacturer
Laboratorios Liconsa
Country
Belgium (BE)
ATC code
C09DA04
ATC class
Irbesartan und Diuretika
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for irbesartan und diuretika.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check irbesartan und diuretika against other medicinesHow interaction checks work

Irbesartan und diuretika · interactions on record

80 records

80 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Irbesartan und diuretika in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All irbesartan und diuretika products

Authorised across Europe · EMA

The same active substance is authorised in 23 EEA countries. Names it is sold under:

  • Austria · Irbepress, Irbesartan Hexal
  • Bulgaria · Ирбесан, Ирбесо
  • Cyprus · Converium, Irbesartan Vocate
  • Czechia · Isame
  • Germany · Irbepress, Irbesartan 1 A Pharma
  • Denmark · Irbesartan Accord, Irbesartan Jubilant
  • Spain · Irbesartán Almus, Irbesartán Alter
  • France · Irbesartan Accord, Irbesartan Arrow
  • United Kingdom (Northern Ireland) · Irbesartan, Irbesartan Accord
  • Greece · Besartan, Irbegen
  • Hungary · Irabel, Irbesartan Sandoz
  • Ireland · Irbesartan Clonmel, Irbesartan Rowa
  • Iceland · Aprovel, Ifirmasta
  • Italy · Abesart, Irbesartan Accord
  • Liechtenstein · Aprovel, Irbesartan Teva
  • Luxembourg · Irbesartan Eg, Irbesartan Viatris
  • Malta · Irbesartan Aurobindo Pharma (Malta)
  • Netherlands · Artibesan, Irbesartan Accord
  • Norway · Aprovel, Ifirmasta
  • Poland · Irbesartan Aurovitas
  • Portugal · Irbesartan Alter, Irbesartan Aurovitas
  • Romania · Irbesartan Terapia
  • Sweden · Irbesartan Accord, Irbesartan Actavis

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f4f1ebb8-4227-4771-9a76-e3caa61792a9
GET /v1/drugs/f4f1ebb8-4227-4771-9a76-e3caa61792a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "source": "afmps",
  "status": "REVOKED",
  "name_en": "Irbesartan/Hydrochlorothiazide Liconsa 300 mg - 12,5 mg",
  "name_fr": "Irbesartan/Hydrochlorothiazide Liconsa 300 mg - 12,5 mg",
  "name_nl": "Irbesartan/Hydrochlorothiazide Liconsa 300 mg - 12,5 mg",
  "amp_code": "SAM382453-00",
  "strengths": [
    "300.0000",
    "12.5000"
  ],
  "pack_count": 4,
  "substances": [
    "Irbesartan",
    "Hydrochlorothiazide"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Irbesartan and Diuretics",
  "authorisation_numbers": [
    "BE382453"
  ]
}
API referenceMCP serverPlans

See everything about irbesartan und diuretika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console